Go Top

彰化基督教醫療財團法人彰化基督教醫院 臨床試驗中心Changhua Christian Medical Foundation Changhua Christian Hospital Clinical Trial Center

  • 病床總數1,648
  • 醫師人數654
  • 地址500彰化縣彰化市校街135號ㄧ期10樓
  • 電子信箱

1. 每年執行約150件新藥臨床試驗

2. 彰化基督教醫療體系含括六家分院及1家合作醫院,建立完善的轉介機制

3. 通過國際臨床研究受試者保護評鑑,並榮獲全面通過(Full Accreditation)殊榮


  1. 於2000年開始執行臨床試驗,並於2007年成立臨床試驗中心,管理及執行臨床試驗計畫,提供優良之臨床試驗品質以及受試者權益之維護。
  2. 具美國研究人員聯盟(Association of Clinical Research Professionals, ACRP) 認證之CCRC以及台灣護理師臨床研究學會認證之臨床研究護理師
  3. 臨床研究護理師朝專科化邁進,建立備援機制
  4. 積極培訓臨床試驗人才,建立教育訓練制度及標準作業流程
  5. 臨床試驗單ㄧ窗口服務
  6. 擁有優良之軟硬體設備
  7. 提供臨床試驗受試者獨立及隱私的空間




  1. Accredited by JCI (Joint Commission International) in 2008, and Reaccredited in 2011 and 2014, 1st Hospital in Taiwan Accredited by 7th JCI (Joint Commission International) in 2017.
  2. Full Accreditation Awarded by AAHRPP (Association for Accreditation of Human Research Protection Program) in 2015 and Reaccredited in 2018.


TFDA inspection with no major finding



  1. 臨床研究護理師專科化:

  2. 人體研究專案管理系統:

  3. 單一窗口服務流程:




Lin, C.H., Kuo, S.C., Hsieh, M.C., Ho, S.Y., Su, I.J., Lin, S.H., …., Yeh, Y.P.(2019). Changhua Research Alliance for Tuberculosis Elimination. Effect of diabetes mellitus on risk of latent TB infection in a high TB incidence area: a community-based study in Taiwan. BMJ Open 2019, 9(10):e029948. doi: 10.1136/bmjopen-2019-029948


Lai, H.W., Liu, L.C., Ouyang, F., Yao, C.C., Jan, H.C., Chang, Y.H., ….Chen, F.M.(2017). Multi-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent® eBx® System for the management of early stage breast cancer in Taiwan. PLoS One. 2017, 2;12(11):e0185876. doi: 10.1371/journal.pone.0185876.


Jackisch, C., Hegg, R., Stroyakovskiy, D., Ahn, JS4, Melichar B, Chen, S.C.,…Pivot, X.(2016). HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated with neoadjuvant-adjuvant trastuzumab after 2 years of treatment-free follow-up. Eur J Cancer, 19(62), 62-75. doi: 10.1016/j.ejca.2016.03.087


Lai, T.H., Wang, W.F., Yip, B.S., Yang, Y.W., Peng, G.S., Tsai, S.J., Liao, Y.C.(2016). Pai Real-world evaluation of compliance and preference in Alzheimer's disease treatment: an observational study in Taiwan. Patient Prefer Adherence, 30(10), 383-90. doi: 10.2147/PPA.S95271.


Wang, L.W., Hsiao, C.F., Chen, W.T., Lee, H.H., Lin, T.C., Chen, H.C., …Liu, T.W. (2014), Celecoxib Plus Chemoradiotherapy for Locally Advanced Rectal Cancer: A Phase II TCOG study, Journal of Surgical Oncology, 109(6), 580-585. doi: 10.1002/jso.23538


Hsu, C., Tsou, H.H., Lin, S.J., Wang, M.C., Yao, M., …Cheng, A.L.(2014), Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study, Hepatology, 59(6), 2092-2100. doi: 10.1002/hep.26718


Chen, P.H., Tsai, Y.T., Wang, J.S., Lin, S.D., Lee, W.J., Su, S.L., Lee, I.T., …Lin, S.Y.(2014). Post-meal β-cell function predicts the efficacy of glycemic control in patients with type 2 diabetes inadequately controlled by metformin monotherapy after addition of glibenclamide or acarbose. Diabetol Metab Syndr. 6(68). doi: 10.1186/1758-5996-6-68


Lai, H.W., Tseng, L.M., Chang, T.W., Kuo, Y.L., Hsieh, C.M., Chen, S.T., Chen, D.R.(2013). The prognostic significance of metaplastic carcinoma of the breast (MCB) - A case controlled comparison study with infiltrating ductal carcinoma. Breast, 22(5), 968-973. doi: 10.1016/j.breast.2013.05.010.


Lu, Y.S., Chen, D.R., Tseng, L.M., Yeh, D.C., Chen, S.T., Hsieh, C.M., …Huang, C.S.(2011). Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer. Cancer Chemotherapy and Pharmacology, 67(6), 1257-1263. doi: 10.1007/s00280-010-1401-2